Antiulcer activity of eel-calcitonin (elcatonin) is associated with enhanced gastric mucosal PGE2 generation in the rat.
- 1 January 1990
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 52 (2) , 379-382
- https://doi.org/10.1254/jjp.52.379
Abstract
Elcatonin is a newly synthetized peptide that prevents experimental ulcer formation. In this study, we examined the influence of elcatonin on endogenous prostaglandin biosynthesis by the gastric mucosa with respect to its antiulcer activity. Control levels of PGE2 generation for the fundic and antral mucosa were 302 .+-. 12 and 465 .+-. 28 ng/g tissue/min, respectively. Pretreatment with elcatonin resulted in a dose-dependent increment in gastric mucosal PGE2 generation. We conclude that the antiulcer effect of elcatonin is probably due to its ability to enhance endogenous prostaglandin synthesis in the gastric mucosa.This publication has 4 references indexed in Scilit:
- Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in ratsDigestive Diseases and Sciences, 1986
- Effects of elcatonin, a synthetic analogue of eel calcitonin, on acute gastric and duodenal lesions and gastroduodenal function in rats.Folia Pharmacologica Japonica, 1986
- Effect of elcatonin on experimental gastric and duodenal ulcers.The Japanese Journal of Pharmacology, 1985
- In vivo suppression of prostaglandin biosynthesis by non-steroidal anti-inflammatory agentsProstaglandins, 1976